Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

67.50
Delayed Data
As of Jan 22
 +3.73 / +5.85%
Today’s Change
8.51
Today|||52-Week Range
129.71
+55.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.8B

Company Description

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Contact Information

Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive
San Diego California 92121
P:(858) 900-2660
Investor Relations:

Employees

Shareholders

Mutual fund holders47.92%
Other institutional30.31%
Individual stakeholders18.39%

Top Executives

Joseph E. PaynePresident, Chief Executive Officer & Director
Padmanabh ChivukulaSecretary, Chief Operating & Scientific Officer
Andrew H. SassineChief Financial Officer & Director
Steven G. HughesChief Development Officer
Keith KummerfeldVice President-Finance & Controller